Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

GD2 Antibody (Naxitamab)

Tundra lists 1 GD2 Antibody (Naxitamab) clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06574698

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

To explore the efficacy of adding anti-GD2 immunotherapy (Naxitamab) at the stage of induction chemotherapy for newly diagnosed high risk neuroblastoma patients. To investigate wether anding Naxitamab in the induction phase will improve the response rate at the end of induction therapy and further improve the overall survival rate.

Gender: All

Ages: 1 Year - 21 Years

Updated: 2024-08-28

1 state

Neuroblastoma

GD2 Antibody (Naxitamab)